Please use this identifier to cite or link to this item:
https://open.uns.ac.rs/handle/123456789/1707
DC Field | Value | Language |
---|---|---|
dc.contributor.author | de Swart L. | en_US |
dc.contributor.author | Smith A. | en_US |
dc.contributor.author | Haase D. | en_US |
dc.contributor.author | Fenaux P. | en_US |
dc.contributor.author | Symeonidis A. | en_US |
dc.contributor.author | Cermak J. | en_US |
dc.contributor.author | Sanz G. | en_US |
dc.contributor.author | Stauder R. | en_US |
dc.contributor.author | Mittelman M. | en_US |
dc.contributor.author | Hellström-Lindberg E. | en_US |
dc.contributor.author | Malcovati L. | en_US |
dc.contributor.author | Langemeijer S. | en_US |
dc.contributor.author | Skov-Holm M. | en_US |
dc.contributor.author | Mądry K. | en_US |
dc.contributor.author | Germing U. | en_US |
dc.contributor.author | Almeida A. | en_US |
dc.contributor.author | Tatic A. | en_US |
dc.contributor.author | Aleksandar Savić | en_US |
dc.contributor.author | Šimec N. | en_US |
dc.contributor.author | van Marrewijk C. | en_US |
dc.contributor.author | Guerci-Bresler A. | en_US |
dc.contributor.author | Sanhes L. | en_US |
dc.contributor.author | Luño E. | en_US |
dc.contributor.author | Culligan D. | en_US |
dc.contributor.author | Beyne-Rauzy O. | en_US |
dc.contributor.author | Burgstaller S. | en_US |
dc.contributor.author | Blijlevens N. | en_US |
dc.contributor.author | Bowen D. | en_US |
dc.contributor.author | de Witte T. | en_US |
dc.date.accessioned | 2019-09-23T10:17:18Z | - |
dc.date.available | 2019-09-23T10:17:18Z | - |
dc.date.issued | 2018-04-01 | - |
dc.identifier.issn | 1452126 | en_US |
dc.identifier.uri | https://open.uns.ac.rs/handle/123456789/1707 | - |
dc.description.abstract | © 2018 Elsevier Ltd Conventional karyotype is one of the most relevant prognostic factors in MDS. However, about 50% of patients with MDS have a normal karyotype. Usually, 20–25 normal metaphases (nMP) are considered to be optimal to exclude small abnormal clones which might be associated with poor prognosis. This study evaluated the impact of examining a suboptimal number of metaphases in patients recruited to the EUMDS Registry with low and intermediate-1 risk according to IPSS. Only 179/1049 (17%) of patients with a normal karyotype had a suboptimal number of nMP, defined as less than 20 metaphases analyzed. The outcome (overall survival and progression-free survival) of patients with suboptimal nMP was not inferior to those with higher numbers of analyzed MP both in univariate and multivariate analyses. For patients with an abnormal karyotype, 224/649 (35%) had a suboptimal number of MP assessed, but this did not impact on outcome. For patients with a normal karyotype and suboptimal numbers of analyzable metaphases standard evaluation might be acceptable for general practice, but we recommend additional FISH-analyses or molecular techniques, especially in candidates for intensive interventions. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Leukemia Research | en_US |
dc.subject | Myelodysplastic syndromes | en_US |
dc.subject | Metaphases | en_US |
dc.subject | Karyotype | en_US |
dc.subject | Cytogenetics | en_US |
dc.subject | Lower-risk | en_US |
dc.subject | Overall survival | en_US |
dc.subject | Progression-free survival | en_US |
dc.title | Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS | en_US |
dc.type | Journal/Magazine Article | en_US |
dc.identifier.doi | 10.1016/j.leukres.2018.01.022 | - |
dc.identifier.pmid | 67 | - |
dc.identifier.scopus | 2-s2.0-85041672268 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85041672268 | - |
dc.description.version | Published | en_US |
dc.relation.lastpage | 26 | en_US |
dc.relation.firstpage | 21 | en_US |
dc.relation.volume | 67 | en_US |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
crisitem.author.dept | Medicinski fakultet, Katedra za internu medicinu | - |
crisitem.author.parentorg | Medicinski fakultet | - |
Appears in Collections: | MDF Publikacije/Publications |
SCOPUSTM
Citations
4
checked on May 10, 2024
Page view(s)
11
Last Week
1
1
Last month
0
0
checked on May 10, 2024
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.